Lupin Ltd Fact Sheet, Lupin Ltd Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Fact Sheet    (LUPL)

Here is the latest financial fact sheet of Lupin Ltd. For more details, see the Lupin Ltd quarterly results and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN Price History

Price Rs 738.8
Mkt Cap Rs m 334,373
Vol '000 64.5
P/E X 47.5
P/CF X 19.7
EPS (TTM) Rs 15.6
% ch % 1.7
No. of shares m 452.59
% ch week % 5.3
% ch 1-mth % -2.7
% ch 12-mth % -15.8
52 week H/L Rs 914.0/646.2
(As on Oct 18, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
LUPIN EQUITY SHARE DATA
High Rs2,0372,1271,7501,465986 
Low Rs9041,2941,384727720 
Sales per share (Unadj.) Rs280.3316.4387.4349.6369.5 
Earnings per share (Unadj.) Rs53.550.256.65.613.4 
Diluted earnings per shareRs53.150.056.55.613.4 
Cash flow per share (Unadj.) Rs63.161.076.829.637.4 
Dividends per share (Unadj.) Rs7.507.507.505.000 
Adj. dividends per shareRs7.457.477.484.990.00 
Dividend yield (eoy) %0.50.40.50.50 
Book value per share (Unadj.) Rs204.1247.8298.9300.3303.7 
Adj. book value per shareRs202.7246.7298.2300.0303.6 
Shares outstanding (eoy) m449.49450.58451.58452.08452.49 
Bonus/Rights/Conversions  ESOP-ESOPESOPESOP 
Price / Sales ratio x5.25.44.03.12.3 
Avg P/E ratio x27.534.127.7197.263.6 
P/CF ratio (eoy) x23.328.020.437.122.8 
Price / Book Value ratio x7.26.95.23.62.8 
Dividend payout %14.014.913.290.00 
Avg Mkt Cap Rs m660,975770,740707,513495,502386,064 
No. of employees `00014.216.416.817.017.7 
Total wages/salary Rs m17,47321,41628,49528,64731,513 
Avg. sales/employee Rs Th8,874.38,718.510,418.39,273.69,453.8 
Avg. wages/employee Rs Th1,230.71,309.81,697.01,681.01,782.0 
Avg. net profit/employee Rs Th1,692.71,382.61,523.0147.4343.0 
LUPIN INCOME DATA
Net Sales Rs m125,997142,555174,943158,042167,182 
Other income Rs m2,3981,8521,0651,5043,640 
Total revenues Rs m128,395144,407176,008159,545170,822 
Gross profit Rs m36,19636,85444,93131,47528,822 
Depreciation Rs m4,3474,8719,12210,85910,850 
Interest Rs m985951,5252,0443,078 
Profit before tax Rs m34,14833,23935,34920,07618,534 
Minority Interest Rs m-412-88-72-71-89 
Prior Period Items Rs m049833538 
Extraordinary Inc (Exp) Rs m000-14,644-3,400 
Tax Rs m9,70410,5939,7852,8859,017 
Profit after tax Rs m24,03222,60725,5752,5136,066 
Gross profit margin %28.725.925.719.917.2 
Effective tax rate %28.431.927.714.448.7 
Net profit margin %19.115.914.61.63.6 
LUPIN BALANCE SHEET DATA
Current assets Rs m78,04098,874119,529122,095138,536 
Current liabilities Rs m34,63350,61261,20650,95661,299 
Net working cap to sales %34.533.933.345.046.2 
Current ratio x2.32.02.02.42.3 
Inventory Days Days7384768584 
Debtors Days Days7711690120112 
Net fixed assets Rs m49,213114,194131,660129,876127,516 
Share capital Rs m899901903904905 
"Free" reserves Rs m90,833110,733134,073134,866136,517 
Net worth Rs m91,732111,634134,976135,771137,422 
Long term debt Rs m1,01853,73956,47864,24566,417 
Total assets Rs m132,610226,249266,073263,054279,494 
Interest coverage x349.156.924.210.87.0 
Debt to equity ratio x00.50.40.50.5 
Sales to assets ratio x1.00.60.70.60.6 
Return on assets %18.210.310.21.73.3 
Return on equity %26.220.318.91.94.4 
Return on capital %36.520.419.33.78.9 
Exports to sales %46.447.2000 
Imports to sales %8.87.2000 
Exports (fob) Rs m58,48267,244000 
Imports (cif) Rs m11,05710,199000 
Fx inflow Rs m62,59371,40581,88553,14159,414 
Fx outflow Rs m16,59217,80721,50619,33522,282 
Net fx Rs m46,00153,59860,37833,80737,132 
LUPIN CASH FLOW
From Operations Rs m 27,331 -3,824 41,135 17,512 16,660 
From Investments Rs m -10,545 -69,617 -25,274 4,699 -32,825 
From Financial Activity Rs m -1,969 58,364 4,332 -14,921 7,441 
Net Cashflow Rs m 14,817 -15,077 20,193 7,290 -8,724 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.6%
Foreign collaborators 0.2%
Indian inst/Mut Fund 11.3%
FIIs 31.9%
ADR/GDR 0.0%
Free float 10.1%
Shareholders 98,259
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
E-MAIL rajvardhansatam@lupinpharma.com WEB www.lupinworld.com
TELEPHONE (022) 6640 2323 FAX (022) 2652 8806
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT In-house
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): -

Read: LUPIN 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   PFIZER  NATCO PHARMA  FDC LTD.  SHASUN PHARMA  J.B.CHEMICALS  

Compare LUPIN With:   PFIZER  NATCO PHARMA  FDC LTD.  SHASUN PHARMA  J.B.CHEMICALS  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Views on news

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN

MORE ON LUPIN

LUPIN - TEVA PHARMA COMPARISON

COMPARE LUPIN WITH

MARKET STATS